Zeitschrift für Genetik und Genome

Advancements in the Treatment of Paragangliomas and Pheochromocytomas in the Era of Precision Medicine

Abstract

Mockler Henk

Paragangliomas and pheochromocytomas are rare neuroendocrine tumors originating from the chromaffin cells of the sympathetic and parasympathetic nervous systems, respectively. While traditionally managed through surgical resection and adjuvant therapies, the advent of precision medicine has revolutionized the approach to diagnosing, treating, and managing these tumors. This article explores the evolving landscape of treatment modalities for paragangliomas and pheochromocytomas in the era of precision medicine.